Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome

Objective Sex hormone-binding globulin (SHBG) is suggested to be a biomarker for metabolic disturbances in women with polycystic ovary syndrome (PCOS). Insulin resistance and hyperinsulinemia is common in PCOS patients. Low SHBG increases free testosterone levels, which further induces hyperinsuline...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bo E. van Bree, Denise M. B. van der Heijden, Ron J. T. van Golde, Martijn C. G. J. Brouwers, Marc E. A. Spaanderman, Olivier Valkenburg
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2025-12-01
Edice:	Gynecological Endocrinology
Témata:	Polycystic ovary syndrome (PCOS) sex hormone-binding globulin (SHBG) metabolic phenotype metabolic syndrome hyperandrogenism
On-line přístup:	https://www.tandfonline.com/doi/10.1080/09513590.2025.2500462
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!